Merck & Co., Inc. (MRK)
146.95
-0.23
(-0.16%)
USD |
NYSE |
Nov 12, 16:00
146.95
0.00 (0.00%)
Pre-Market: 04:46
Merck Price to Book Value : 8.075 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 8.075 |
| November 11, 2026 | 8.087 |
| November 10, 2026 | 8.135 |
| November 09, 2026 | 8.174 |
| November 06, 2026 | 8.062 |
| November 05, 2026 | 8.074 |
| November 04, 2026 | 8.262 |
| November 03, 2026 | 7.949 |
| November 02, 2026 | 8.152 |
| October 30, 2026 | 8.216 |
| October 29, 2026 | 8.040 |
| October 28, 2026 | 7.744 |
| October 27, 2026 | 7.793 |
| October 26, 2026 | 7.726 |
| October 23, 2026 | 7.982 |
| October 22, 2026 | 8.090 |
| October 21, 2026 | 8.236 |
| October 20, 2026 | 8.149 |
| October 19, 2026 | 7.892 |
| October 16, 2026 | 8.020 |
| October 15, 2026 | 7.978 |
| October 14, 2026 | 8.098 |
| October 13, 2026 | 7.802 |
| October 12, 2026 | 7.992 |
| October 09, 2026 | 8.000 |
| Date | Value |
|---|---|
| October 08, 2026 | 7.824 |
| October 07, 2026 | 7.846 |
| October 06, 2026 | 7.799 |
| October 05, 2026 | 7.667 |
| October 02, 2026 | 7.929 |
| October 01, 2026 | 7.902 |
| September 30, 2026 | 7.984 |
| September 29, 2026 | 8.788 |
| September 28, 2026 | 8.754 |
| September 25, 2026 | 8.759 |
| September 24, 2026 | 8.712 |
| September 23, 2026 | 8.718 |
| September 22, 2026 | 8.884 |
| September 21, 2026 | 8.801 |
| September 18, 2026 | 8.646 |
| September 17, 2026 | 8.663 |
| September 16, 2026 | 8.531 |
| September 15, 2026 | 8.465 |
| September 14, 2026 | 8.528 |
| September 11, 2026 | 8.473 |
| September 10, 2026 | 8.519 |
| September 09, 2026 | 8.685 |
| September 08, 2026 | 8.74 |
| September 04, 2026 | 8.850 |
| September 03, 2026 | 8.968 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.371 |
| Eli Lilly & Co. | 33.36 |
| Pfizer Inc. | 1.846 |
| Bristol Myers Squibb Co. | 5.443 |
| Abbott Laboratories | 3.640 |
Price to Book Value Related Metrics
| PE Ratio | 150.07 |
| PS Ratio | 5.414 |
| Price to Free Cash Flow | 24.68 |
| Price | 146.95 |
| Earnings Yield | 0.67% |
| Market Cap | 362.49B |
| Operating PE Ratio | 29.39 |
| Normalized PE Ratio | 49.19 |